表紙：脳・神経イメージング装置市場の2030年までの予測：イメージングタイプ、手技、用途、エンドユーザー、地域別の世界分析

市場調査レポート

商品コード

1371992

脳・神経イメージング装置市場の2030年までの予測：イメージングタイプ、手技、用途、エンドユーザー、地域別の世界分析

Brain and Neuroimaging Devices Market Forecasts to 2030 - Global Analysis By Imaging Type, Procedure, Application, End User and By Geography

出版日: 2023年10月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 609,303円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 770,805円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 932,307円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,101,150円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の脳・神経画像機器市場は2023年に224億米ドルを占め、予測期間中にCAGR 7.1％で成長し、2030年には362億米ドルに達する見込みです。

脳および神経画像診断装置は、脳の構造、機能、薬理を把握し、神経障害の影響を受ける部位を特定するために使用される医療機器です。ニューロイメージングとして知られる医療用画像診断の分野では、脳に焦点が当てられています。ニューロイメージングでは、疾患の特定や脳の健康状態の評価に加え、脳がどのように機能しているかを調査します。神経科学者は、脳画像装置を用いて生きた脳の内部を見ることができます。

米国国立衛生研究所によると、神経変性疾患に対する資金は2020年に40億2,100万米ドルとなります。

技術の進歩

技術の進歩により、脳・神経画像診断装置の機能性と有効性は向上しています。例えば、機能的磁気共鳴画像法（fMRI）や拡散テンソル画像法（DTI）のような高解像度画像技術のイントロダクションより、脳の解剖学的構造と機能を調べる能力が向上しました。さらに、技術の進歩の結果、より早く、より快適にスキャンを完了することが可能になったため、市場は現在も成長を続けています。

高額な画像診断機器

脳・神経画像技術の市場は、画像診断機器の高コストによる影響を受けると予測されます。認知心理学や神経学におけるブレイン・コンピューター・インターフェイスの調査には、機能的磁気共鳴画像法（fMRI）、陽電子放射断層撮影法（PET）、脳波計（EEG）などのハイエンド機器が必要です。しかし、これらは高価な装置であり、特に発展途上国では、すべての病院や研究所が購入できるわけではないです。したがって、病院や診断研究所の購買力を制限する画像診断システムの高コストが、脳・神経画像診断装置市場の障壁となっています。

個別化医療と精密画像診断

個別化医療の目的は、脳の構造や機能など、患者固有の特徴に合わせて医療を変更することです。神経画像技術は、より良い治療計画や神経学的状態のモニタリングのために、個人に合わせた情報を提供する上で非常に有用です。さらに、患者固有のバイオマーカーを見つけ、治療成績を向上させるために、機能的結合マッピングやマルチモーダル画像統合を含む精密画像アプローチが開発されており、市場を拡大しています。

規制上の課題

脳・神経イメージング機器の市場は、欧州医薬品庁（EMA）や米国食品医薬品局（FDA）などの規制当局による厳しい規則や認可の対象となります。さらに、新しい画像技術や機器の規制当局の認可や承認を得るには、時間と費用がかかる場合があります。この分野の企業は、進化する規制規範や基準を遵守することの難しさに直面しています。こうした規制上の課題が市場成長の妨げとなっています。

COVID-19の影響

COVID-19の流行は、市場や神経画像診断装置の分野にさまざまな影響を及ぼしています。医療従事者がウイルスが脳に及ぼした影響や関連する神経症状を正確に理解しようとしたため、臨床現場ではMRIやCTスキャンのような神経画像診断ツールの使用が増加しました。その結果、これらの機器や関連技術の需要が高まっています。この流行により、医療機器、特に神経画像診断機器の生産と流通が遅れ、供給網が寸断されました。

予測期間中、外来手術センターセグメントが最大になる見込み

外来手術センターセグメントが最大シェアを占めると推定されます。脳・神経画像診断装置市場において、外来手術センター（ASCs）セグメントは神経疾患の診断・管理において特に重要です。これらの施設は、神経外科手術やインターベンショナル・ラジオロジープロシージャーのような様々な医療介入を行う外来患者の場として頻繁に機能しており、神経画像診断技術は極めて重要な機器です。ヘルスケアシステムが外来患者ケアと低侵襲手技を優先させる中、神経画像機器はASC内の診断・治療経路にとって今後も重要です。

予測期間中、脳オキシメータ分野のCAGRが最も高くなる見込み

脳オキシメータセグメントは予測期間中に有利な成長が見込まれます。脳酸素濃度レベルの測定と評価を専門とする脳オキシメータは、脳と神経イメージングデバイス産業に不可欠な部分です。近赤外分光法（NIRS）システムを含むこれらのツールは、脳組織の酸素飽和レベルを非侵襲的に検出し、大脳の健康状態を評価するための重要な情報を提供するために不可欠です。手術室、新生児治療室、研究室など様々な医療現場で、脳の健康状態に関する洞察に満ちた情報を提供するため、これらの機器の使用が増加しています。

最大のシェアを占める地域

アジア太平洋地域は、高度なヘルスケア・インフラ、充実した研究開発投資、神経疾患の有病率の高さにより、推定期間中に最大の市場シェアを獲得しました。病院、クリニック、研究施設の広大なネットワークを持つ北米は、世界で最も洗練されたヘルスケア・インフラのひとつです。このようなインフラがあるため、研究にも臨床診断にも神経画像技術の入手と利用が容易です。この地域では、多数の神経損傷、多発性硬化症、アルツハイマー病、パーキンソン病、その他の疾患が比較的一般的です。

CAGRが最も高い地域：

欧州は予測期間中、収益性の高い成長が見込まれます。欧州は、強力なヘルスケアシステム、最先端の医療技術、神経疾患への関心の高まりを特徴としています。現代的な病院、クリニック、研究施設のネットワークは、欧州の確立された広範なヘルスケアインフラの一部です。このインフラは、臨床診断や学術研究への神経画像技術の導入と利用を奨励しています。早期診断、疾患モニタリング、研究のために、この高い疾患有病率が神経画像技術の改善の必要性を高めています。多くの欧州諸国では、支払いに関する有利な規制のおかげで、神経画像診断法が患者や医療専門家により広く利用されるようになっています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Canon
Hitachi Medical Systems
General Electric Company
Philips
Varian Medical Systems
Siemens
Toshiba Medical Systems
NeuroSoft
Sanrad Medical Systems Pvt. Ltd
Esaote SpA
Medtronic Plc
Elekta AB
Natus Medical Incorporated
Magstim Company Ltd.
Compumedics Limited
Brainlab AG

図表

List of Tables

Table 1 Global Brain and Neuroimaging Devices Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 3 Global Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 4 Global Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 5 Global Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 6 Global Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 7 Global Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 8 Global Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 9 Global Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 10 Global Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 11 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 12 Global Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)

Table Global Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)

Table 13 Global Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 14 Global Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 15 Global Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 16 Global Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 17 Global Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 18 Global Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 19 Global Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 20 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 21 Global Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 22 Global Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 23 Global Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 24 Global Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 25 Global Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 26 Global Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 27 Global Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 28 Global Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 29 Global Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 30 North America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
Table 31 North America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 32 North America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 33 North America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 34 North America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 35 North America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 36 North America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 37 North America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 38 North America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 39 North America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 40 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 41 North America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table 42 North America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
Table 43 North America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 44 North America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 45 North America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 46 North America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 47 North America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 48 North America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 49 North America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 50 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 51 North America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 52 North America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 53 North America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 54 North America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 55 North America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 56 North America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 57 North America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 58 North America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 59 North America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 60 Europe Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
Table 61 Europe Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 62 Europe Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 63 Europe Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 64 Europe Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 65 Europe Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 66 Europe Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 67 Europe Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 68 Europe Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 69 Europe Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 70 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 71 Europe Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table 72 Europe Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
Table 73 Europe Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 74 Europe Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 75 Europe Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 76 Europe Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 77 Europe Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 78 Europe Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 79 Europe Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 80 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 81 Europe Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 82 Europe Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 83 Europe Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 84 Europe Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 85 Europe Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 86 Europe Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 87 Europe Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 88 Europe Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 89 Europe Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 90 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
Table 91 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 92 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 93 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 94 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 95 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 96 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 97 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 98 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 99 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 100 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 101 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table 102 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
Table 103 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 104 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 105 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 106 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 107 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 108 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 109 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 110 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 111 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 112 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 113 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 114 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 115 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 116 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 117 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 118 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 119 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 120 South America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
Table 121 South America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 122 South America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 123 South America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 124 South America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 125 South America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 126 South America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 127 South America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 128 South America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 129 South America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 130 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 131 South America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table 132 South America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
Table 133 South America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 134 South America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 135 South America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 136 South America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 137 South America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 138 South America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 139 South America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 140 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 141 South America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 142 South America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 143 South America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 144 South America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 145 South America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 146 South America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 147 South America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 148 South America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 149 South America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 150 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
Table 151 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
Table 152 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
Table 153 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
Table 154 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
Table 155 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
Table 156 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
Table 157 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
Table 158 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
Table 159 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
Table 160 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
Table 161 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table 162 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
Table 163 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
Table 164 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
Table 165 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
Table 166 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
Table 167 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
Table 168 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
Table 169 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
Table 170 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
Table 171 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
Table 172 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
Table 173 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
Table 174 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
Table 175 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
Table 176 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 177 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 178 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 179 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)

Product Code: SMRC24048

According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.

According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.

Market Dynamics:

Driver:

Technology advancements

Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.

Restraint:

High cost of imaging equipment

The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.

Opportunity:

Personalized medicine and precision imaging

The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.

Threat:

Regulatory challenges

The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.

COVID-19 Impact

The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.

The ambulatory surgical centers segment is expected to be the largest during the forecast period

The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.

The cerebral oximeters segment is expected to have the highest CAGR during the forecast period

The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.

Key players in the market:

Some of the key players in the Brain and Neuroimaging Devices Market include: Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.

Key Developments:

In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.

In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.

Imaging Types Covered:

Computed Tomography
Functional Magnetic Resonance Imaging
Positron Emission Tomography
Electroencephalography
Near Infrared Spectroscopy
Magneto encephalography
Intracranial Pressure Monitors
Cerebral Oximeters
Sleep Monitoring Devices
Electromyography Devices
Other Imaging Types

Procedures Covered:

Invasive
Non-Invasive

Applications Covered:

Traumatic Brain Injury
Dementia
Parkinson's Disease
Sleep Disorders
Epilepsy
Huntington's Disease
Headache Disorders
Other Applications

End Users Covered:

Ambulatory Surgical Centers
Diagnostic Centers
Hospitals
Clinics

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Brain and Neuroimaging Devices Market, By Imaging Type

5.1 Introduction
5.2 Computed Tomography
5.3 Functional Magnetic Resonance Imaging
5.4 Positron Emission Tomography
5.5 Electroencephalography
5.6 Near Infrared Spectroscopy
5.7 Magnetoencephalography
5.8 Intracranial Pressure Monitors
5.9 Cerebral Oximeters
5.10 Sleep Monitoring Devices
5.11 Electromyography Devices
5.12 Other Imaging Types

6 Global Brain and Neuroimaging Devices Market, By Procedure

6.1 Introduction
6.2 Invasive
6.3 Non-Invasive

7 Global Brain and Neuroimaging Devices Market, By Application

7.1 Introduction
7.2 Traumatic Brain Injury
7.3 Dementia
7.4 Parkinson's Disease
7.5 Sleep Disorders
7.6 Epilepsy
7.7 Huntington's Disease
7.8 Headache Disorders
7.9 Other Applications

8 Global Brain and Neuroimaging Devices Market, By End User

8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Diagnostic Centers
8.4 Hospitals
8.5 Clinics

9 Global Brain and Neuroimaging Devices Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Canon
11.2 Hitachi Medical Systems
11.3 General Electric Company
11.4 Philips
11.5 Varian Medical Systems
11.6 Siemens
11.7 Toshiba Medical Systems
11.8 NeuroSoft
11.9 Sanrad Medical Systems Pvt. Ltd
11.10 Esaote SpA
11.11 Medtronic Plc
11.12 Elekta AB
11.13 Natus Medical Incorporated
11.14 Magstim Company Ltd.
11.15 Compumedics Limited
11.16 Brainlab AG